OCR Text |
Show 1 U E D V ••» V SCHOOL OF MEDICINE AND HEALTH SCIENCES UNDERGRADUATE RESEARCH ABSTRACTS Daniel Alan Keesler mm. Joshua Zimmerman Jennifer DeCou James Agutter 122 IDENTIFICATION AND COMMUNICATION OF UNDIAGNOSED IMPAIRED FASTING GLUCOSE (IFG) Daniel Alan Keesler (Joshua Zimmerman, Jennifer DeCou, James Agutter) College of Architecture + Planning, Honors College University of Utah Overall Goal: To understand the prevalence of undiagnosed diabetes and impaired fasting glucose in the University Hospital surgical population and to develop a system to direct patients to the appropriate care. Background: Diabetes mellitus is an increasingly prevalent disease in the United States and throughout the world. O n e technique used in diagnosing diabetes mellitus (DM) or pre-diabetes (impaired fasting glucose, IFG) is a fasting glucose value in which one's blood sugar is measured after at least 8 hours of fasting. Undiagnosed and untreated D M and IFG can cause many health issues including micro-vascular and macro-vascular disease, retinopathy, neuropathy, and cardiovascular disease. IFG can be a useful indicator of patients at risk for progression towards D M. Methods: Data is collected from the Preoperative Clinic at the University of Utah Hospital. Many patients w h o are preparing to undergo surgery have a basic metabolic panel (BMP) ordered, which includes a blood glucose level. Since a pre-operative patient arrives fasting in preparation for surgery, this provides an opportunity to screen them for IFG. Information is retrieved from the electronic medical record for patients with fasting glucose levels >100 mg/dL '. Using this data, a letter is written to the patient's primary care physician, notifying them of their patient's recent abnormal fasting glucose level. Results: Of the patients that went through the Preoperative Clinic between August 27, 2012 and November 6,2012, there were 150 patients that had BMPs drawn. IFG or diabetic blood sugar levels were measured for 87 patients. Of those 87 patients, 47 reported no diagnosis of IFG or D M . The overall prevalence of undiagnosed IFG or D M was 31.3%. Next Steps: Understanding the prevalence of IFG, we can refine our data collection methods and streamline the notification of abnormal lab results to patients and their physicians. W e can also use this data to estimate the prevalence of undiagnosed IFG and D M hospital wide. With a prevalence of 31.3% undiagnosed IFG and DM, it is evident that there is an opportunity for increased patient care. The early diagnosis of IFG will help prevent progression to D M and improve quality of care. Ultimately, the goal is to route patients to the appropriate care, where they can receive treatment for their pre-diabetes or diabetes. Prevalence of Undiagnosed IFG and D M (150 patients observed) • Normogrycemla • Known diabetes/pre-diabetes • New diabetes/pre-diabetes 1. Rao, Shobha, Disraeli, Phillip, McGregor, Tamara. (2004, April 15). Impaired Glucose Tolerance and Impaired Fasting Glucose. Retrieved from http://www.aafp.org/afp/2004/0415/p1961.html |